Jun 304 min readMedNews: Holoclara closes $16 Million financing to advance worm-derived therapies for allergic and autoimmune diseaseThe company’s discovery engine builds on Dr. Choe’s research uncovering a unique pheromone language shared by roundworms
May 293 min readMedNews: MediLink Therapeutics enters into a multi-target technology platform license with the immunotherapy company BioNTech (Nasdaq: BNTX) for therapies for cancer and other serious diseasesMediLink Therapeutics, founded in 2020, is a clinical stage biotech company dedicated to developing conjugated drugs